THE NICKLES GROUP, LLC for BAXTER HEALTHCARE CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 3200, America's Affordable Health Choices Act of 2009, H.R. 3590, The Patient Protection and Affordable Care Act, H.R. 3962, Affordable Health Care for America Act, as they relate to new fees on manufacturers of drugs and medical devices and to taxation of employer-sponsored health coverage. Issues related to the taxation of foreign earnings of U.S. multinational corporations. H.R. 4213, the Tax Extenders Act of 2009, as it relates to the R&D tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | U.S. Senate Budget Committee, Tax Policy Director |
Copyright/Patent/Trademark CPT
S. 515 / S. 610 / H.R. 1260 Patent Reform Act of 2009, all issues related to patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA MERIFIELD TRIPODI | U.S. Senator Don Nickles, Legislative Assistant |
| JEFF MURRAY | U.S. Rep. Tom Feeney, Legislative Counsel |
Health Issues HCR
Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. S. 701, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage and payment for IVIG administered in the home. H.R. 3200, America's Affordable Health Choices Act of 2009, H.R. 3590, The Patient Protection and Affordable Health Care Act, and H.R. 3962, Affordable Health Care for America Act, as they relate to fees on manufacturers of drugs & medical devices, Medicaid rebates, Medicare reimbursement for drugs & access to IVIG for Medicare beneficiaries, and taxation of employer-sponsored health coverage. S. 525, S. 1232 / H.R. 1298, the Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUG BADGER | Deputy Assistant to the President for Leg. Affairs |
| MARY BETH SAVARY TAYLOR | Joint Economic Committee, General Counsel |
Medicare/Medicaid MMM
Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. S. 701, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage & payment for IVIG administered in the home. H.R. 3200, America's Affordable Health Choices Act of 2009, H.R. 3590, The Patient Protection and Affordable Health Care Act, and H.R. 3962, Affordable Health Care for America Act as they relate to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices, and access to IVIG for Medicare beneficiaries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUG BADGER | Deputy Assistant to the President for Leg. Affairs |
| MARY BETH SAVARY TAYLOR | Joint Economic Committee, General Counsel |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.